Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)
Clinical trial NCT03688074 · COMPLETED
Trial details
- NCT number
- NCT03688074
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-02
- Primary completion
- 2020-11-16
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.